Kezar Life Sciences, Inc. Logo

Kezar Life Sciences, Inc.

Developing novel small molecule therapies for immune-mediated diseases and oncology.

KZR | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
4000 SHORELINE COURT, SUITE 300, 94080 SOUTH SAN FRANCISCO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kezar Life Sciences, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel, first-in-class small molecule therapeutics. The company advances unique protein-targeting approaches designed to inhibit multiple disease-driving cellular pathways, addressing the limitations of available treatments. Its development pipeline focuses on creating therapies for difficult-to-treat, immune-mediated chronic diseases and oncology. Kezar aims to develop breakthrough treatments for patients with significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Kezar Life Sciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kezar Life Sciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kezar Life Sciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bestone.Com Co.,Ltd Logo
An online travel agency specializing in domestic and overseas cruise tours and tickets.
Japan 6577
BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea 251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea 086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America BOLT

Talk to a Data Expert

Have a question? We'll get back to you promptly.